Severe acute respiratory syndrome Coronavirus 2 (SARS-COV-2) is a virus with positive single-stranded RNA as a genome and is responsible for the worldwide COVID-19 pandemic that started in Wuhan, China. SARS-CoV-2 is a beta-coronavirus of the
Coronaviridae family (
1). The genome structure and sequence of SARS-CoV-2 indicate high similarity with those of SARS coronavirus 1 and have several structural and nonstructural proteins that have a pivotal role in virus replication, pathogenicity, and transmission (
2,
3). RNA synthesis is a necessary process that involves several steps, including genome replication and sub-genomic RNA transcription. Viral RNA synthesis is not a perfect process, and some errors such as point mutation and recombination can occur during the process, which can affect the detection process by PCR detection kits (
4).
Some processes, such as sequencing the SARS-CoV-2 genome in patient's samples, provide beneficial information about viral genome characteristics, reducing false negatives, and increasing the sensitivity and specificity of real-time PCR kits (
5). Orf 1ab, N, and RdRp are three regions mainly used for virus detection in different PCR diagnostic kits (
6). In some studies, the S region was also used for detection, but the false-negative rate increased compared to that in the other regions (
7,
8). On the other hand, the sensitivity of the PCR test is another factor that can affect the rate of false negative. Several studies have revealed that real-time PCR is not the best technique to diagnose infectious agents such as SARS-CoV-2. Nested PCR can indicate sensitivity ten times better than real-time polymerase chain reaction (RT-PCR) (
9). A decrease in the false-negative rate can help prevent virus transmission through the community and disrupt the replication cycle of the virus.